Global Digital Mammography Market By Product Type (2D Full Field Digital Mammography, 3D Full Field Digital Mammography, and Contrast Enhanced Digital Mammography), By End-use (Hospitals, Diagnostic Centers, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

Global Digital Mammography Market size is expected to be worth around US$ 6.8 billion by 2033 from US$ 2.5 billion in 2023, growing at a CAGR of 10.5% during the forecast period 2024 to 2033. In 2023, North America led the market, achieving over 40.3% share with a revenue of US$ 1.0 Billion.

Growing concerns over the rising prevalence of breast cancer drive the expansion of the digital mammography market, as these advanced imaging systems play a crucial role in early diagnosis and treatment planning. Digital mammography offers improved accuracy, faster image acquisition, and better image storage and retrieval compared to traditional methods, contributing to enhanced patient care.

According to the World Health Organization (WHO), around 2.3 million cases of breast cancer were reported worldwide in 2022, resulting in approximately 670,000 deaths, highlighting the urgent need for effective screening technologies. The increasing adoption of digital mammography systems is driven by advancements in imaging technology, including high-definition detectors and 3D mammography, which improve the detection of breast tumors, especially in dense breast tissue.

Opportunities for growth also arise from the rising demand for personalized healthcare, where digital mammography helps tailor more accurate treatment plans based on early detection. The integration of artificial intelligence (AI) and machine learning algorithms into digital mammography systems further enhances diagnostic accuracy by identifying subtle patterns and anomalies in breast tissue.

Additionally, healthcare providers are increasingly investing in systems that enable real-time analysis, improving workflow efficiency and reducing patient wait times. As awareness about breast cancer screening continues to rise, both public and private healthcare sectors are expected to increase their investments in advanced diagnostic technologies, further propelling the digital mammography market.

Key Takeaways

• In 2023, the market for Digital Mammography generated a revenue of US$ 2.5 billion, with a CAGR of 10.5%, and is expected to reach US$ 6.8 billion by the year 2033.
• The product type segment is divided into 2D full field digital mammography, 3D full field digital mammography, and contrast enhanced digital mammography, with 2D full field digital mammography taking the lead in 2023 with a market share of 55.2%.
• Considering end-use, the market is divided into hospitals, diagnostic centers, and others. Among these, hospitals held a significant share of 63.8%.
• North America led the market by securing a market share of 40.3% in 2023.

Product Type Analysis

The 2D full field digital mammography segment led in 2023, claiming a market share of 55.2% owing to its established position in breast cancer screening. This technology provides high-quality images, which aid in the early detection of breast abnormalities, a key factor contributing to its continued adoption. Hospitals and diagnostic centers are likely to favor 2D systems because of their lower cost compared to 3D systems while still offering effective screening capabilities.

The growing focus on preventative healthcare, particularly in countries with rising incidences of breast cancer, is anticipated to further drive demand for 2D mammography systems. In addition, technological advancements, such as improved image processing techniques and reduced radiation doses, are projected to enhance the efficacy of 2D systems, making them even more attractive for routine breast cancer screenings. As healthcare budgets remain constrained in many regions, the affordability of 2D digital mammography is likely to be a significant growth driver in the coming years.

By End-use Analysis

The hospitals held a significant share of 63.8% as healthcare facilities continue to invest in advanced diagnostic technologies. Hospitals are expected to increasingly adopt digital mammography systems to improve diagnostic accuracy and speed, which is critical for timely breast cancer detection and treatment. The growing awareness of breast cancer and its early detection is anticipated to drive more patients to seek screenings in hospital settings.

Additionally, hospitals are likely to expand their breast care units, driven by rising demand for cancer diagnosis services. The continuous advancements in digital imaging technology, which enable better resolution and faster image capture, are estimated to further boost hospital adoption. Furthermore, the expansion of healthcare infrastructure in emerging markets is expected to enhance the availability of these advanced diagnostic systems in hospitals, contributing to the segment’s growth.

Key Market Segments

By Product Type

• 2D Full Field Digital Mammography
• 3D Full Field Digital Mammography
• Contrast Enhanced Digital Mammography

By End-use

• Hospitals
• Diagnostic Centers
• Others

Drivers

Rising Prevalence of Breast Cancer Drives the Digital Mammography Market

Growing prevalence of breast cancer drives the digital mammography market. According to data from Breastcancer.org, approximately 287,850 new cases of invasive breast cancer are expected in the United States in 2022, in addition to 51,400 new cases of non-invasive breast cancer. As the incidence of breast cancer rises globally, the demand for early detection technologies, such as digital mammography, is likely to increase significantly.

Digital mammography systems offer enhanced image clarity, faster results, and improved diagnostic accuracy, which are essential for the early detection of breast cancer. Healthcare providers are anticipated to adopt these advanced imaging systems to facilitate early diagnosis and improve patient outcomes. With advancements in technology, digital mammography systems are projected to become more accessible and cost-effective, encouraging widespread use in both developed and emerging markets.

The rising awareness of breast cancer, along with government screening programs, is likely to further boost the demand for digital mammography in the coming years. As a result, the market for these imaging systems is expected to experience substantial growth, driven by the global need for better detection tools to combat the rising breast cancer burden.

Restraints

High Costs Restrain the Digital Mammography Market

One key restraint in the digital mammography market is the high cost associated with these advanced imaging systems. Digital mammography machines require significant upfront investment, both for the initial purchase and for ongoing maintenance and calibration. Hospitals, especially in emerging markets, may struggle to afford these technologies due to limited budgets or lack of reimbursement for advanced imaging procedures.

Although digital mammography systems offer superior diagnostic capabilities, the expense of installing and maintaining such equipment may prevent some healthcare facilities from adopting them. Additionally, the need for trained radiologists to interpret digital mammogram results further adds to the operational costs.

As a result, healthcare systems with tight budgets may prioritize other medical technologies over digital mammography, limiting market growth in certain regions. These financial barriers may slow the adoption of digital mammography, particularly in low- and middle-income countries, where healthcare resources are more constrained.

Opportunities

Rising Government Initiatives Create Growth Opportunities for the Market

Rising government initiatives present a significant opportunity for the digital mammography market. With increasing awareness around the importance of early breast cancer detection, governments worldwide are expected to boost investments in screening programs. For example, the Goa government’s “Swasth Mahila, Swasth Goa” initiative, launched in October 2021, aims to provide free breast cancer screenings for 100,000 women.

This initiative is anticipated to drive the adoption of advanced diagnostic technologies, including digital mammography, in both urban and rural regions. Such efforts are likely to reduce the burden of breast cancer by promoting early detection and improving treatment outcomes.

Moreover, as governments continue to prioritize public health and preventive care, the demand for efficient, cost-effective, and high-resolution imaging systems is projected to rise. These initiatives not only increase market demand but also highlight the growing need for accessible and reliable diagnostic tools, further fueling the expansion of the digital mammography market.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors significantly influence the growth of the digital mammography market. On the positive side, rising healthcare spending in developing regions and government initiatives to improve early cancer detection are driving demand for advanced screening technologies. Increased awareness about breast cancer, coupled with supportive healthcare policies, is expected to boost the market further.

However, economic downturns and inflationary pressures can lead to reduced healthcare budgets, delaying investments in expensive diagnostic equipment. Additionally, geopolitical tensions and supply chain disruptions can affect the availability of critical components for mammography systems, potentially hindering market growth.

Despite these challenges, the market is projected to remain resilient due to continued technological advancements and the expanding adoption of preventative healthcare practices, fostering long-term growth.

Latest Trends

Rising Use of Modern Technologies like AI Driving Growth in Digital Mammography

Rising adoption of modern technologies such as artificial intelligence (AI) is significantly driving the digital mammography market. AI algorithms are anticipated to improve diagnostic accuracy and efficiency, making breast cancer detection faster and more reliable.

In April 2024, researchers from Yonsei University in the Republic of Korea introduced an AI deep learning model for breast cancer diagnosis using digital breast tomosynthesis (DBT). The model outperformed radiologists in diagnostic accuracy and drastically reduced image reading times, illustrating the profound impact of AI.

The integration of such innovations is likely to increase patient throughput, optimize workflows, and enhance early detection, making digital mammography more accessible globally. These advancements are expected to improve outcomes and contribute to a positive shift toward personalized medicine, further propelling market growth.

Regional Analysis

North America is leading the Digital Mammography Market

North America dominated the market with the highest revenue share of 40.3% owing to various factors. A key driver has been the increasing awareness about breast cancer and the importance of early detection. With advancements in technology, digital mammography offers better image quality and faster results, leading to enhanced diagnostic accuracy.

This has significantly contributed to the rise in the adoption of digital mammography systems across hospitals and clinics. Additionally, healthcare policies focusing on early breast cancer screening have further fueled market expansion. The growing number of women in North America seeking routine screening is another contributing factor.

Moreover, ongoing research and development in improving the technology behind digital mammography systems have increased their affordability and accessibility. These factors, combined with the growing healthcare infrastructure in North America, have made digital mammography an integral part of breast cancer screening, resulting in a continuous rise in market demand.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia Pacific is expected to grow with the fastest CAGR owing to a combination of factors. Increasing awareness about breast cancer, along with government initiatives like the Greater Chennai Corporation’s breast cancer awareness campaigns, is likely to boost demand for screening technologies. In 2020-2021, approximately 1.17 lakh women in Chennai were screened for breast cancer, demonstrating a growing inclination toward preventive healthcare.

Furthermore, countries like India and China are anticipated to invest heavily in healthcare infrastructure, which will facilitate the adoption of digital mammography. Initiatives such as the Punjab government’s partnership with Roche Pharma India and Niramai Health in launching the PINK Project will further increase the reach of breast cancer screening.

As healthcare systems modernize and disposable income rises in these countries, the market for advanced diagnostic tools like digital mammography is projected to expand rapidly. The increasing focus on early detection and improved patient outcomes will likely propel this market forward in the coming years.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

Key players in the digital mammography market leverage several strategies to fuel growth, including expanding product portfolios through innovation and mergers with complementary technology firms. Companies focus on developing advanced systems with higher resolution and improved imaging capabilities, addressing the increasing demand for early breast cancer detection. Strategic partnerships with healthcare providers and research institutions help enhance their market presence and accelerate product adoption.

Players are also investing in global expansion, particularly in emerging markets, to increase accessibility. Additionally, significant investments in R&D enable the continuous development of cutting-edge, cost-effective solutions tailored to meet patient and healthcare provider needs.

Hologic, a leader in medical imaging technology, stands out as a key player in the digital mammography market. Headquartered in Marlborough, Massachusetts, the company specializes in breast health, diagnostics, and medical imaging systems.

Hologic’s strong commitment to innovation, coupled with its extensive product range, allows it to address diverse needs within the diagnostic imaging space. The company’s investments in research and development, combined with strategic acquisitions like that of SuperSonic Imagine, bolster its position in the rapidly growing market. Hologic’s focus on expanding its global reach and enhancing clinical efficacy continues to drive its success in improving patient outcomes.

Top Key Players

• Siemens Healthineers
• Landwind Medical
• IDETEC Medical Imaging
• Hologic
• GE Healthcare
• Fujifilm
• DR Tech Corp
• Diagnostic Medical Systems

Recent Developments

• In September 2023, Hologic joined forces with Bayer to advance the use of contrast-enhanced mammography (CEM) across Canada, Europe, and select regions of Asia-Pacific. CEM utilizes intravenously administered iodinated contrast agents to enhance cancer detection. This partnership was formed to offer a complete product package and training resources designed to facilitate the widespread adoption of CEM.
• In April 2024, Siemens Healthineers announced the approval of its MAMMOMAT B. Brilliant by the FDA under 510(k) clearance. This new mammography platform offers a comprehensive redesign, incorporating advanced features such as digital mammography, breast biopsy, and enhanced contrast imaging with titanium for more accurate results.

Report Scope